Skip Navigation National Cancer Institute U.S. National Institutes of Health www.cancer.gov
 

Fighting HIV/AIDS and HIV Malignancies through...

HIV/AIDS and HIV Malignancy Research in the NCI:

The NCI has played a major role in HIV/AIDS research since the beginning of the epidemic, when a cluster of cases of Kaposiís sarcoma was one of the harbingers of this new disease. NCI scientists have made a number of key discoveries in both HIV/AIDS and AIDS-associated cancer. Today, this research is carried out in multiple Divisions and Offices of the NCI.   |   Learn More

OHAMís Role:

OHAM is responsible for coordinating and overseeing HIV/AIDS research throughout the NCI. In addition, it directly oversees a number of programs in AIDS-related cancer as well as HIV/AIDS.   |   Learn More

   Spotlight

Learn more about the new NCI-supported clinical trial, Anal Cancer HSIL Outcomes Research (ANCHOR) Study

NCI and the Fogarty International Center announce the awardees to the Sub-Saharan Africa Collaborative HIV and Cancer Consortia


   Funding Opportunities View All    News and Events

Excess cancer incidence in HIV-positive people.

15th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) to be held October 26-27, 2015 (tentative dates) at the NIH Campus in Bethesda, MD.

HIV-Positive Patients with Lymphoma should be eligible for Stem Cell Transplants.

The Annual Conference on Retroviruses and Opportunistic Infections (CROI) to be held February 23-26, 2015 in Seattle, Washington.

NCIís investigators Hughes and colleagues describe a new paradigm in HIV reservoir research